| Financial Year |
March 31 2023 |
| Monetary Funds |
3,287,021,323.13 |
| Held-for-trading Financial Assets |
2,000,000.00 |
| Notes Receivable |
2,309,902,664.03 |
| Accounts Receivable |
3,917,317,599.69 |
| Advances to Suppliers |
521,013,139.93 |
| Other Receivables |
127,475,656.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,047,286,598.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
235,947,099.92 |
| Total Current Assets |
13,448,532,429.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
85,351,568.29 |
| Investment Properties |
21,839,628.71 |
| Fixed Assetes |
11,845,973,433.27 |
| Under-construction Projects |
1,644,900,554.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,625,996,739.87 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
25,444,353.16 |
| Deferred Income Tax Assets |
121,047,581.31 |
| Other Non-Current Assets |
2,997,253,624.28 |
| Sub-Total of Non-Current Assets |
20,559,423,170.38 |
| Total Assets |
34,007,955,599.71 |
| Short-Term Loans |
3,771,199,573.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,164,039,020.05 |
| Accounts Payable |
3,989,764,924.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
69,127,420.60 |
| Taxes Payable |
210,720,305.81 |
| Interest Payable |
23,372,088.32 |
| Dividend Payable |
1,357,000.00 |
| Other payables |
451,070,619.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
833,384,886.04 |
| Other Current Liabilities |
5,169,514.70 |
| Sub-Total of Current Liabilities |
10,593,658,199.90 |
| Long-term Loans |
4,871,867,500.00 |
| Bonds Payable |
3,629,896,018.14 |
| Long-Term Accounts Payable |
133,013,319.55 |
| Special Payable |
-- |
| Estimatied Liabilities |
6,457,941.49 |
| Deferred Income Tax Liabilities |
169,254,032.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,878,738,656.92 |
| Total Liabilities |
19,472,396,856.82 |
| Paid-In Capital(Or Share Stock) |
536,723,541.75 |
| Capital Surplus |
4,869,881,909.93 |
| Surplus Reserve |
268,361,745.88 |
| LESS:Treasury Stock |
23,806,600.00 |
| Undistributed Profits |
8,335,204,500.05 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,535,558,742.89 |
| Owner's Equity（Stockholder's Equity） |
14,535,558,742.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
34,007,955,599.71 |
